# Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage

> **NCT06361433** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Hokkaido University Hospital** · enrollment: 8 (estimated)

## Conditions studied

- Intracerebral Hemorrhage

## Interventions

- **DRUG:** HUFF-01

## Key facts

- **NCT ID:** NCT06361433
- **Lead sponsor:** Hokkaido University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-01
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2024-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06361433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06361433, "Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06361433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*